• Can changes in EEG improve neuropathic pain treatments - read Oct newsletter.
  • Nine posters ready to reveal at the SfN virtual conference 8-11 Nov, booth 1818.
  • Joined-up preclinical and clinical trials to advance psilocybin drug development
  • Transpharmation joins HaPpY team to help break the vicious cycle of chronic pain & mood disorders, see News for details
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • New state-of-the-art premises at Discovery Park, Kent
 

Cognition CRO Services

We conduct preclinical studies based around cognition of the brain

The Transpharmation team has considerable understanding in preclinical cognition research gained through decades of working experience running disease area portfolios for Alzheimer’s disease, Schizophrenia within GlaxoSmithKline. Importantly, our highly skilled technical staff appreciate the subtleties involved in evaluating rodent cognitive processes, ensuring all our assays are highly robust and reproducible.Transpharmation has considerable understanding in preclinical cognition research gained through decades of experience running disease area portfolios for Alzheimer’s disease, Parkinson’s disease and Schizophrenia within GlaxoSmithKline. Importantly, our highly skilled technical staff appreciate the subtleties involved in evaluating rodent cognitive processes, ensuring all our assays are highly robust and reproducible.

Our Focus when it comes to Cognition CRO

We mainly focus on delivering carefully selected cognition models which are disease-relevant thereby offering the option to evaluate NCEs against pharmacologically induced cognition impairments, (e.g scopolamine) or natural impairments, (age, test parametric manipulation) across multiple disease areas.

Examples of the Cognition CRO models we offer include the following:

  • Novel object recognition
    • temporal deficit
    • pharmacological deficit, (scopolamine, sub-chronic PCP)
  • Delayed-non-match to position
  • Reversal learning
  • Attentional set shifting

cognition modelTo discuss your requirements further and get your project underway please do not hesitate to speak with us. We are always developing new areas of discovery within our preclinical field of expertise. If there is something particular that is not listed here please do contact us.

Start a Conversation

preclinical +44 (0)203 633 2807

clinical trials +353 (0)1896 42 60

clinical research +48 515 244 120

EEG contact@transpharmation.co.uk


Copyright ©2021 Transpharmation Ltd. Website created by Identity Ipswich Web Design